急性呼吸窘迫综合征合并肺动脉高压的治疗进展  

Advances in Treatment of Acute Respiratory Distress Syndrome With Pulmonary Hypertension

作　　者：薛华 韩锋[2] 张岩[3] 翟梅 李满祥[4] 

机构地区：[1]咸阳市第一人民医院呼吸科,陕西咸阳712000 [2]西安交通大学第二附属医院重症医学科,陕西西安710004 [3]西安交通大学第二附属医院心内科,陕西西安710004 [4]西安交通大学第一附属医院呼吸科,陕西西安710061

出　　处：《中国继续医学教育》2017年第1期91-93,共3页China Continuing Medical Education

摘　　要：急性呼吸窘迫综合征合并肺动脉高压是临床危重症,呼吸支持治疗是急性呼吸窘迫综合征合并肺动脉高压的基础治疗方案,在呼吸支持治疗的基础上给予合理用药,控制过度全身性炎症反应,促进促炎/抗炎平衡的恢复,对治疗急性呼吸窘迫综合征合并肺动脉高压至关重要。急性呼吸窘迫综合征合并肺动脉高压的治疗药物包括NO吸入、钙离子增敏剂、前列腺素、HMG-Co A还原酶抑制剂、磷酸二酯酶-5-抑制剂等。综合考虑多种病理机制,联合多种药物,或药物与非药物干预联合应用是目前较为公认的急性呼吸窘迫综合征合并肺动脉高压的治疗方向。Acute respiratory distress syndrome complicated pulmonary hypertension is a clinical critically ill. Respiratory support therapy is the basis of the acute respiratory distress syndrome complicated pulmonary hypertension treatment. Respiratory support therapy on the basis of reasonable drug use. Control excessive systemic inflammatory response. Promote recovery of pro-inflammatory/anti-inflammatory balance. For the treatment of acute respiratory distress syndrome combined pulmonary hypertension is very important. The treatment of acute respiratory distress syndrome with pulmonary hypertension drugs including NO inhalation, calcium sensitization agent, prostaglandins, HMG Co-A reductase inhibitors, phosphodiesterase-5-inhibitor, phosphodiesterase inhibitors, etc. Considering a variety of pathological mechanism, combined a variety of drugs, or drug and non-drug intervention combined with application is now recognized as acute respiratory distress syndrome treated with pulmonary hypertension.

关 键 词：急性呼吸窘迫综合征 肺动脉高压 治疗 

分 类 号：R563[医药卫生—呼吸系统]